维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Kaeda"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia显示文摘	Hughes TP Kaeda J Branford S		0，，15：	1
2	Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia显示文摘	Kaeda J Branford S	2003	N Engl J Med2003，349，15：	1
3	Increased frequencies of CD4^+ CD25^high Tregs correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia 显示文摘	Nadal E Garin M Kaeda J	2007	Leukemia2007，21，3：	1
4	Targeting primary human leukaemia cells with RNA interference: Bcr-Abl targeting: inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells 显示文摘	WITHEY JM MARLEY SB KAEDA J	2005	BrJ Haematol2005，129，：	1
5	A new glucose-6 phosphate dehydrogenase variant, G6PD Orissa (44 AlaGly), is the major polymorphie variant in tribal populations in India 显示文摘	Kaeda JS Chhotray GP Ranjit MR	1995	AmJ HumGenet1995，57，6：	1
6	Three major G6PD-deficient polymorphic variants identified among the Mauritian population 显示文摘	Kotea R Kaeda JS Yan SL	1999	BrJ Haematol1999，104，4：	1
7	Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplant for chronic myeloid leukemia:an attempt to define patients who may not require further therapy显示文摘	Kaeda J O' Shea D Szydlo RM	2006	Blood2006，107，：	1
8	Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia:an analysis from the International Randomized Study of Interferon and STI571(IRIS)显示文摘	Hughes T P Kaeda J Branford S	2010	Blood2010，116，：	1
9	Targeting primary human leukaemia cells with RNA interference:Bcr-Abl targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells显示文摘	Withey JM Martey SB Kaeda J	2005	Br J Haematol2005，129，3：	1
10	Severe hemolytic anemia associated with the homozygous state for an unstable hemoglobin variant ( nb Bushwick) 显示文摘	Srivastava P Kaeda JS Roper D	1995	Blood1995，86，5：	1
11	Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia 显示文摘	Hughes TP Kaeda J Branford S	2003	N Engl J Med2003，349，：	1
12	Cytogenetic and molecular monitoring of residual disease in chronic myeloid leukaemia 显示文摘	Kaeda J Chase A Goldman JM	2002	Acta Haematol2002，107，2：	1
13	Increased frequencies of CD4+CD25 high Tregs correlate with disease relapse after allogeneic stem cell transplantation for ehronie myeloid leukemia显示文摘	Nadal E Garin M Kaeda J	2007	Leukemia2007，21，3：	1
14	Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib:patterns of residual leukaemia and prog- nostic factors for cytogenetic relapse显示文摘	Marin D Kaeda J Szydlo R	2005	Leukemia2005，19，4：	1
15	Targeting primary human leukaemia cells with RNA interference: Bcr-Abl targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells显示文摘	Withey J M Marley S B Kaeda J	2005	Br J Haematol2005，129，3：	1
16	Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia 显示文摘	Hughes TP Kaeda J Branford S	2003	N Engl J Med2003，349，15：	1
17	International Randomised Study of Interferon versus STL571 (IRIS) Study Group, Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia 显示文摘	Hughes TP Kaeda J Branford S	2003	N Engl J Med2003，349，：	1
18	Frequency of major molecular responses to imatinib or interferon alpha plus cytarabine in newly diagnosed chronic myeloid leukemia显示文摘	Hughes TP Kaeda J Branford S	2003	New Engl J Med2003，349，15：	1
19	A pilot study of continuous ima- tinibvspulsedimatinib with or without G-CSF in CML patientswho have a- chieved a complete cytogenetic response 显示文摘	Drummond MW Heaney N Kaeda J	2009	Leukemia2009，23，：	1
20	A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response 显示文摘	Drummond MW Heaney N Kaeda J	2009	Leukemia2009，23，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示